Susquehanna Fundamental Investments’s Health Catalyst HCAT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,673	Closed	-$81.7K	–	656
2025 Q2	$81.7K	Sell	21,673 -41,226	-66%	-$162K	﹤0.01%	700
2025 Q1	$285K	Sell	62,899 -51,101	-45%	-$270K	﹤0.01%	955
2024 Q4	$806K	Buy	+114,000	New	+$908K	0.01%	766
2024 Q2	$1.08M	Buy	169,529 +26,196	+18%	+$168K	0.03%	539
2024 Q1	$1.08M	Buy	+143,333	New	+$1.31M	0.05%	337
2023 Q1	–	Sell	-46,694	Closed	-$496K	–	1012
2022 Q4	$496K	Sell	46,694 -48,217	-51%	-$465K	0.01%	866
2022 Q3	$921K	Buy	+94,911	New	+$1.26M	0.02%	830

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Susquehanna Fundamental Investments's HCAT Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 21,673 shares — an estimated $81.7K sold.

Susquehanna Fundamental Investments first reported a position in HCAT in Q3 2022 and held it in 7 quarters. The position peaked at $1.08M in Q2 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

Susquehanna Fundamental Investments reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 21,673 Health Catalyst shares in Q3 2025, an estimated $81.7K.
Susquehanna Fundamental Investments first reported a position in Health Catalyst in Q3 2022 and held it in 7 quarters.
Susquehanna Fundamental Investments's Health Catalyst position peaked at $1.08M in Q2 2024.
145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.